Cargando…
Is There A Systemıc Inflammatory Effect of Cholesteatoma?
Introduction Inflammation causes squamous epithelial transformation of the mucosa in the middle ear cavity and plays a role in the onset, growth, spread, and recurrence of cholesteatoma. Objectives The objective of this study is to investigate the systemic inflammatory effect in chronic otitis with...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme-Revinter Publicações Ltda
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5205518/ https://www.ncbi.nlm.nih.gov/pubmed/28050207 http://dx.doi.org/10.1055/s-0036-1584363 |
_version_ | 1782490093657784320 |
---|---|
author | Kılıçkaya, M. Mustafa Aynali, Giray Tuz, Mustafa Bagcı, Özkan |
author_facet | Kılıçkaya, M. Mustafa Aynali, Giray Tuz, Mustafa Bagcı, Özkan |
author_sort | Kılıçkaya, M. Mustafa |
collection | PubMed |
description | Introduction Inflammation causes squamous epithelial transformation of the mucosa in the middle ear cavity and plays a role in the onset, growth, spread, and recurrence of cholesteatoma. Objectives The objective of this study is to investigate the systemic inflammatory effect in chronic otitis with cholesteatoma. Methods The study included a total of 311 patients comprising 156 patients with a pathology diagnosis of cholesteatoma and a control group of 155 with no active inflammation. The Neutrophil-to-lymphocyte Ratio (NLR) was calculated by dividing the neutrophil value by the lymphocyte value. Results The mean NLR was 1.94 ± 0.91 in the patients with cholesteatoma and 1.94 ± 0.85 in the control group. We determined no statistically significant difference between the groups in respect of NLR (p = 0.983). We calculated the NLR as 2.01 ± 1.00 in patients with ossicle erosion and 1.82 ± 0.69 in those without ossicle erosion, 1.86 ± 0.85 in patients with bone erosion and 1.98 ± 0.95 in those without bone erosion. We determined no statistical difference between these values (p = 0.175). Conclusion The results of this study showed that NLR had no predictive value in respect of bone erosions and associated complications in patients with cholesteatoma. The inflammatory effect of cholesteatoma is not systemic but remains more local. |
format | Online Article Text |
id | pubmed-5205518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Thieme-Revinter Publicações Ltda |
record_format | MEDLINE/PubMed |
spelling | pubmed-52055182017-01-03 Is There A Systemıc Inflammatory Effect of Cholesteatoma? Kılıçkaya, M. Mustafa Aynali, Giray Tuz, Mustafa Bagcı, Özkan Int Arch Otorhinolaryngol Introduction Inflammation causes squamous epithelial transformation of the mucosa in the middle ear cavity and plays a role in the onset, growth, spread, and recurrence of cholesteatoma. Objectives The objective of this study is to investigate the systemic inflammatory effect in chronic otitis with cholesteatoma. Methods The study included a total of 311 patients comprising 156 patients with a pathology diagnosis of cholesteatoma and a control group of 155 with no active inflammation. The Neutrophil-to-lymphocyte Ratio (NLR) was calculated by dividing the neutrophil value by the lymphocyte value. Results The mean NLR was 1.94 ± 0.91 in the patients with cholesteatoma and 1.94 ± 0.85 in the control group. We determined no statistically significant difference between the groups in respect of NLR (p = 0.983). We calculated the NLR as 2.01 ± 1.00 in patients with ossicle erosion and 1.82 ± 0.69 in those without ossicle erosion, 1.86 ± 0.85 in patients with bone erosion and 1.98 ± 0.95 in those without bone erosion. We determined no statistical difference between these values (p = 0.175). Conclusion The results of this study showed that NLR had no predictive value in respect of bone erosions and associated complications in patients with cholesteatoma. The inflammatory effect of cholesteatoma is not systemic but remains more local. Thieme-Revinter Publicações Ltda 2016-06-06 2017-01 /pmc/articles/PMC5205518/ /pubmed/28050207 http://dx.doi.org/10.1055/s-0036-1584363 Text en © Thieme Medical Publishers |
spellingShingle | Kılıçkaya, M. Mustafa Aynali, Giray Tuz, Mustafa Bagcı, Özkan Is There A Systemıc Inflammatory Effect of Cholesteatoma? |
title | Is There A Systemıc Inflammatory Effect of Cholesteatoma? |
title_full | Is There A Systemıc Inflammatory Effect of Cholesteatoma? |
title_fullStr | Is There A Systemıc Inflammatory Effect of Cholesteatoma? |
title_full_unstemmed | Is There A Systemıc Inflammatory Effect of Cholesteatoma? |
title_short | Is There A Systemıc Inflammatory Effect of Cholesteatoma? |
title_sort | is there a systemıc inflammatory effect of cholesteatoma? |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5205518/ https://www.ncbi.nlm.nih.gov/pubmed/28050207 http://dx.doi.org/10.1055/s-0036-1584363 |
work_keys_str_mv | AT kılıckayammustafa isthereasystemıcinflammatoryeffectofcholesteatoma AT aynaligiray isthereasystemıcinflammatoryeffectofcholesteatoma AT tuzmustafa isthereasystemıcinflammatoryeffectofcholesteatoma AT bagcıozkan isthereasystemıcinflammatoryeffectofcholesteatoma |